Analysts expect Tiziana Life Sciences Ltd to report revenue of 0.00 for 2021, against a range of 0.00 to 0.00. The most recent reported year, 2025, came in at 0.00.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Reported (Actual) | - | 0.00 | - | 0.00 | 0.00 | |
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analysts expect Tiziana Life Sciences Ltd to report earnings per share of -0.15 for 2026, against a range of -0.16 to -0.14. The most recent reported year, 2025, came in at -0.16, a 5.9% beat against the -0.17 consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Reported (Actual) | -0.26 | -0.15 | -0.15 | -0.10 | -0.16 | - |
| High Estimate | -0.11 | -0.33 | -0.14 | -0.12 | -0.16 | -0.14 |
| Low Estimate | -0.13 | -0.39 | -0.16 | -0.14 | -0.18 | -0.16 |
| Consensus Estimate | -0.12 | -0.36 | -0.15 | -0.13 | -0.17 | -0.15 |